Isthmus Partners’s Bristol-Myers Squibb BMY Stock Holding History

Isthmus Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,767	Closed	-$213K	–	213
2024 Q4	$213K	Buy	+3,767	New	+$210K	0.03%	209
2021 Q3	–	Sell	-3,017	Closed	-$202K	–	163
2021 Q2	$202K	Buy	+3,017	New	+$197K	0.04%	147
2020 Q1	–	Sell	-87,193	Closed	-$5.6M	–	138
2019 Q4	$5.6M	Buy	+87,193	New	+$4.99M	1.27%	41
2019 Q2	–	Sell	-78,030	Closed	-$6.79M	–	147
2019 Q1	$6.79M	Buy	+78,030	New	+$3.89M	1.65%	30
2018 Q4	–	Sell	-3,205	Closed	-$199K	–	152
2018 Q3	$199K	Hold	3,205	–	–	0.05%	123
2018 Q2	$177K	Sell	3,205 -300	-9%	-$16.2K	0.05%	126
2018 Q1	$222K	Hold	3,505	–	–	0.06%	126
2017 Q4	$215K	Hold	3,505	–	–	0.06%	125
2017 Q3	$223K	Hold	3,505	–	–	0.06%	125
2017 Q2	$195K	Sell	3,505 -200	-5%	-$10.9K	0.06%	128
2017 Q1	$201K	Hold	3,705	–	–	0.06%	127
2016 Q4	$217K	Hold	3,705	–	–	0.07%	127
2016 Q3	$185K	Hold	3,705	–	–	0.06%	128
2016 Q2	$273K	Sell	3,705 -200	-5%	-$14.1K	0.09%	117
2016 Q1	$249K	Sell	3,905 -20	-0.5%	-$1.26K	0.08%	118
2015 Q4	$270K	Sell	3,925 -300	-7%	-$19.8K	0.09%	122
2015 Q3	$250K	Hold	4,225	–	–	0.09%	122
2015 Q2	$281K	Hold	4,225	–	–	0.09%	121
2015 Q1	$273K	Sell	4,225 -2	-0%	-$125	0.09%	117
2014 Q4	$250K	Buy	+4,227	New	+$238K	0.09%	125

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Isthmus Partners's BMY Position: Q1 2025 in Review

Isthmus Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 3,767 shares — an estimated $213K sold.

Isthmus Partners first reported a position in BMY in Q4 2014 and held it in 20 quarters. The position peaked at $6.79M in Q1 2019. 2,485 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Isthmus Partners reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Isthmus Partners sold 3,767 Bristol-Myers Squibb shares in Q1 2025, an estimated $213K.
Isthmus Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 20 quarters.
Isthmus Partners's Bristol-Myers Squibb position peaked at $6.79M in Q1 2019.
2,485 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Isthmus Partners's 13F filing for Q1 2025, filed 1 May 2025.